Related Experiment Video
Updated: Jul 29, 2025
Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
Immunopathology of Extracellular Vesicles in Macrophage and Glioma Cross-Talk
Timothy J Kopper1, Xiaoli Yu1, Michael W Graner1
1Department of Neurosurgery, University of Colorado Anschutz Medical Campus, 12700 E 19th Ave., Aurora, CO 80045, USA.
Abstract:
Glioblastomas (GBM) are a devastating disease with extremely poor clinical outcomes. Resident (microglia) and infiltrating macrophages are a substantial component of the tumor environment. In GBM and other cancers, tumor-derived extracellular vesicles (EVs) suppress macrophage inflammatory responses, impairing their ability to identify and phagocytose cancerous tissues. Furthermore, these macrophages then begin to produce EVs that support tumor growth and migration. This cross-talk between macrophages/microglia and gliomas is a significant contributor to GBM pathophysiology. Here, we review the mechanisms through which GBM-derived EVs impair macrophage function, how subsequent macrophage-derived EVs support tumor growth, and the current therapeutic approaches to target GBM/macrophage EV crosstalk.
Insights
Glioblastomas (GBM) and their associated macrophages communicate via extracellular vesicles (EVs). This crosstalk impairs anti-tumor immunity and promotes cancer progression, highlighting a critical therapeutic target.
Area of Science:
- Neuro-oncology
- Cancer biology
- Immunology
Background:
- Glioblastomas (GBM) present a significant clinical challenge due to poor outcomes.
- Macrophages, including microglia, are key components of the GBM tumor microenvironment.
- Tumor-derived extracellular vesicles (EVs) are known to modulate immune cell function in cancer.
Purpose of the Study:
- To review the mechanisms of Glioblastoma (GBM)-derived EVs in suppressing macrophage functions.
- To examine how macrophages, influenced by GBM, produce EVs that promote tumor growth.
- To discuss current therapeutic strategies targeting the Glioblastoma/macrophage extracellular vesicle (EV) crosstalk.
Main Methods:
- Literature review of studies investigating Glioblastoma (GBM) and macrophage interactions.
- Analysis of mechanisms involving extracellular vesicle (EV) mediated communication.
- Synthesis of current therapeutic approaches targeting this crosstalk.
Main Results:
- GBM-derived EVs inhibit macrophage inflammatory responses and phagocytic activity.
- Macrophages exposed to GBM EVs generate their own EVs that enhance tumor growth and migration.
- This bidirectional EV communication significantly contributes to Glioblastoma pathophysiology.
Conclusions:
- The Glioblastoma (GBM)/macrophage crosstalk mediated by extracellular vesicles (EVs) is a critical factor in tumor progression.
- Targeting this EV-mediated communication represents a promising therapeutic avenue for GBM treatment.
